Earth Life Sciences Inc. CLTS
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -75.49% | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -75.49% | -- | -- | -- | -- |
| Operating Income | 75.49% | -- | -- | -- | -- |
| Income Before Tax | 74.64% | -- | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 74.64% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.64% | -- | -- | -- | -- |
| EBIT | 75.49% | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 81.25% | -- | -- | -- | -- |
| Normalized Basic EPS | 80.00% | -- | -- | -- | -- |
| EPS Diluted | 81.25% | -- | -- | -- | -- |
| Normalized Diluted EPS | 80.00% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 42.85% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 42.85% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |